Answers are grounded in this paper and cite their sources.
Chronic depression and anxiety can be a risk factor for coronary aArtery bypass grafting (CABG) and is an emerging factor after coronary artery disease when the patient is admitted to the hospital and after surgery. We aimed to assess the effect of Escitalopram in treating mild to moderate depressive disorder and improving the quality of life in patients undergoing CABG.
No takes yet. Share an insight, caveat, or question.
Baradaran et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: